News
-
-
-
-
PRESS RELEASE
Lobe Sciences Reports Fiscal 2025 Results and Highlights Strategic Transformation Following Leadership Transition
Lobe Sciences Ltd. reports fiscal year 2025 audited financial results, significant balance sheet improvements, and strategic transformation initiatives. Details on key financial highlights and operational progress provided -
-
-
-
-
-
PRESS RELEASE
Lobe Sciences Ltd. and Cynaptec Pharmaceuticals, Inc. to Present a New Therapeutic Approach for the Treatment of Chronic Cluster Headaches at Clusterbusters 2025
Lobe Sciences Ltd. to participate in Clusterbusters 20th Annual U.S. Patient Conference to highlight psilocin treatment for cluster headaches and discuss funding success for further research and development